Literature DB >> 6461912

Immune responses to atypical mycobacterial lung infections.

F M Collins, S R Watson.   

Abstract

Various species of atypical mycobacteria exhibited a wide range of growth patterns in the lung, liver, and spleen of specific pathogen-free B6D2 mice infected with these organisms. The growth varied from rapid elimination (complete avirulence) to a continued persistence in the lung, which eventually resulted in the death of many of the mice. Prior depletion of the T cells of aerogenically challenged mice did not affect the growth characteristics of the organisms within the lungs. Mice infected with Mycobacterium habana developed an early hypersensitivity response to the cytoplasmic protein antigens (CPA) of this organism, and this response was followed by a persistent state of anergy. Mice infected with Mycobacterium simiae failed to develop detectable levels of hypersensitivity at any time during the study. Spleen cells taken from mice infected with M. habana or M. simiae exhibited an early peak in the incorporation of [3H] thymidine after exposure of the cells to the nonspecific T-cell mitogen phytohemagglutinin (PHA). A similar peak occurred when the cells were exposed to the specific mitogen CPA of M. habana. Later in the infection, the anergic spleen cells showed no transformation of lymphocytes after exposure to either PHA or CPA. T-cell-mixing experiments, which were carried out both before and after treatment of suspensions of cells from the anergic spleens with anti-Thy 1.2 antiserum plus complement, indicated the presence of a population of suppressor T cells in the anergic animals.

Entities:  

Mesh:

Year:  1981        PMID: 6461912     DOI: 10.1093/clinids/3.5.981

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  7 in total

1.  Protection of mice from Mycobacterium avium infection by recombinant interleukin-12.

Authors:  K Kobayashi; T Kasama; J Yamazaki; M Hosaka; T Katsura; T Mochizuki; K Soejima; R M Nakamura
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

Review 2.  Beige mouse model for Mycobacterium avium complex disease.

Authors:  P R Gangadharam
Journal:  Antimicrob Agents Chemother       Date:  1995-08       Impact factor: 5.191

3.  T-cell-mediated immunity in persistent Mycobacterium intracellulare infections in mice.

Authors:  T Takashima; F M Collins
Journal:  Infect Immun       Date:  1988-11       Impact factor: 3.441

4.  Interleukin-12-stimulated natural killer cells can activate human macrophages to inhibit growth of Mycobacterium avium.

Authors:  L E Bermudez; M Wu; L S Young
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

Review 5.  The Mycobacterium avium complex.

Authors:  C B Inderlied; C A Kemper; L E Bermudez
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

6.  Growth of Mycobacterium avium in activated macrophages harvested from inbred mice with differing innate susceptibilities to mycobacterial infection.

Authors:  R W Stokes; F M Collins
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

7.  Site-directed mutagenesis of the 19-kilodalton lipoprotein antigen reveals No essential role for the protein in the growth and virulence of Mycobacterium intracellulare.

Authors:  E Mahenthiralingam; B I Marklund; L A Brooks; D A Smith; G J Bancroft; R W Stokes
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.